Royal Society of Chemistry, RSC Advances, 40(10), p. 23767-23774, 2020
DOI: 10.1039/d0ra04210b
Full text: Download
A nanobody/streptavidin-binding peptide fusion protein was developed and proved to be a very promising immunological diagnosis reagent for disease-related biomarkers.